Role of calpain in apoptosis

Cell Journal

Volumn 13, Issue 2, 2011, Pages 65-72

  Momeni, Hamid Reza ^a  

^a ARAK UNIVERSITY   (Iran)

Author keywords

Apoptosis; Calpain; Calpain substrates

Indexed keywords

CALCIUM ION; CALPAIN; CALPAIN 1; CALPAIN 2; CALPAIN 3; CALPASTATIN; EGTAZIC ACID; LEUPEPTIN; SJA 6017; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BIOCHEMISTRY; BRAIN CELL; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CELL STRUCTURE; CELL SURVIVAL; DEGENERATIVE DISEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; HUMAN; HUNTINGTON CHOREA; MOTONEURON; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PROTEIN DEGRADATION; PROTEIN HYDROLYSIS; PROTEIN PROTEIN INTERACTION; RETINA NERVE CELL; REVIEW; SPINAL CORD NERVE CELL;

EID: 80054782313     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972; 26(4): 239-257.
2. Compton MM. A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev. 1992; 11(2): 105-119.
3. Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol. 1991; 32(223-254).
4. Vaux DL. Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci U S A. 1993; 90(3): 786-789. (Pubitemid 23053894)
5. Sendtner M, Pei G, Beck M, Schweizer U, Wiese S. Developmental motoneuron cell death and neurotrophic factors. Cell Tissue Res. 2000; 301(1): 71-84. (Pubitemid 30459856)
6. Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer. 1994; 73(8): 2013-2026. (Pubitemid 24107952)
7. Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev MoI Cell Biol. 2000; 1(2): 120-129.
8. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. Cytometry in cell neurobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry. 1997; 27(1): 1-20. (Pubitemid 27059777)
9. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980; 284(5756): 555-556. (Pubitemid 10070336)
10. Matassov D, Kagan T, Leblanc J, Sikorska M, Zakeri Z. Measurement of apoptosis by DNA fragmentation. Methods MoI Biol. 2004; 282: 1-17.
11. Johnson DE. Noncaspase proteases in apoptosis. Leukemia. 2000; 14(9): 1695-1703.
12. Sorimachi H, Ishiura S, Suzuki K. Structure and physiological function of calpains. Biochem J. 1997; 328 (721-732). (Pubitemid 28005767)
13. Ray SK, Hogan EL, Banik NL. Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Rev. 2003; 42(2): 169-185. (Pubitemid 36549175)
14. Wingrave JM, Schaecher KE, Sribnick EA, Wilford GG, Ray SK, Hazen-Martin DJ, et al. Early induction of secondary injury factors causing activation of calpain and mitochondria-mediated neuronal apoptosis following spinal cord injury in rats. J Neurosci Res. 2003; 73(1): 95-104. (Pubitemid 36791374)
15. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev. 2003; 83(3): 731-801. (Pubitemid 36828925)
16. Tsuji T, Shimohama S, Kimura J, Shimizu K. m-Calpain (calcium-activated neutral proteinase) in Alzheimer's disease brains. Neurosci Lett. 1998; 248(2): 109-112. (Pubitemid 28275944)
17. Mouatt-Prigent A, Karlsson JO, Agid Y, Hirsch EC. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience. 1996; 73(4): 979-987. (Pubitemid 26194324)
18. Ueyama H, Kumamoto T, Fujimoto S, Murakami T, Tsuda T. Expression of three calpain isoform genes in human skeletal muscles. J Neurol Sci. 1998; 155(2): 163-169. (Pubitemid 28139015)
19. Ray SK, Shields DC, Saido TC, Matzelle DC, Wilford GG, Hogan EL, et al. Calpain activity and translational expression increased in spinal cord injury. Brain Res. 1999; 816(2): 375-380. (Pubitemid 29225384)
20. Ray SK, Neuberger TJ, Deadwyler G, Wilford G, DeVries GH, Banik NL. Calpain and calpastatin expression in primary oligodendrocyte culture: preferential localization of membrane calpain in cell processes. J Neurosci Res. 2002; 70(4): 561-569. (Pubitemid 35253526)
21. Momeni HR, Azadi S, Kanje M. Calpain activation and apoptosis in motor neurons of cultured adult mouse spinal cord. Funct Neurol. 2007; 22(2): 105-110. (Pubitemid 47249616)
22. Pietrobon D, Di Virgilio F, Pozzan T. Structural and functional aspects of calcium homeostasis in eukaryotic cells. Eur J Biochem. 1990; 193(3): 599-622. (Pubitemid 20381689)
23. Neumar RW, Meng FH, Mills AM, Xu YA, Zhang C, Welsh FA, et al. Calpain activity in the rat brain after transient forebrain ischemia. Exp Neurol. 2001; 170(1): 27-35. (Pubitemid 32641771)
24. Suzuki K, Sorimachi H. A novel aspect of calpain activation. FEBS Lett. 1998; 433(1-2): 1-4. (Pubitemid 28386719)
25. Suzuki K, Hata S, Kawabata Y, Sorimachi H. Structure, activation, and biology of calpain. Diabetes. 2004; 53 Suppl 1: S12-8. (Pubitemid 38168687)
26. Emori Y, Kawasaki H, Imajoh S, Imahori K, Suzuki K. Endogenous inhibitor for calcium-dependent cysteine protease contains four internal repeats that could be responsible for its multiple reactive sites. Proc Natl Acad Sci U S A. 1987; 84(11): 3590-3594. (Pubitemid 17088326)
27. Averna M, de Tullio R, Passalacqua M, Salamino F, Pontremoli S, Melloni E. Changes in intracellular calpastatin localization are mediated by reversible phosphorylation. Biochem J. 2001; 354(Pt 1): 25-30. (Pubitemid 32183440)
28. Kawasaki H, Kawashima S. Regulation of the calpain-calpastatin system by membranes. Mol Membr Biol. 1996; 13(4): 217-224.
29. Melloni E, Michetti M, Salamino F, Minafra R, Pontremoli S. Modulation of the calpain autoproteolysis by calpastatin and phospholipids. Biochem Biophys Res Commun. 1996; 229(1): 193-197. (Pubitemid 27013730)
30. Saido TC, Sorimachi H, Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. Faseb J. 1994; 8(11): 814-822.
31. Stys PK, Jiang Q. Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons. Neurosci Lett. 2002; 328(2): 150-154. (Pubitemid 34804732)
32. Santella L, Carafoli E. Calcium signaling in the cell nucleus. Faseb J. 1997; 11(13): 1091-1109. (Pubitemid 27481433)
33. Pontremoli S, Melloni E, Viotti PL, Michetti M, Salamino F, Horecker BL. Identification of two calpastatin forms in rat skeletal muscle and their susceptibility to digestion by homologous calpains. Arch Biochem Biophys. 1991; 288(2): 646-652.
34. Saido TC, Yokota M, Nagao S, Yamaura I, Tani E, Tsuchiya T, et al. Spatial resolution of fodrin proteolysis in postischemic brain. J Biol Chem. 1993; 268(33): 25239-25243. (Pubitemid 23335551)
35. Ray SK, Matzelle DD, Wilford GG, Hogan EL, Banik NL. Inhibition of calpain-mediated apoptosis by E-64 d-reduced immediate early gene (IEG) expression and reactive astrogliosis in the lesion and penumbra following spinal cord injury in rats. Brain Res. 2001; 916(1-2): 115-126. (Pubitemid 32971912)
36. Matsumura Y, Saeki E, Otsu K, Morita T, Takeda H, Kuzuya T, et al. Intracellular calcium level required for calpain activation in a single myocardial cell. J MoI Cell Cardiol. 2001; 33(6): 1133-1142. (Pubitemid 32579280)
37. Rosser BG, Powers SP, Gores GJ. Calpain activity increases in hepatocytes following addition of ATP. Demonstration by a novel fluorescent approach. J Biol Chem. 1993; 268(31): 23593-23600. (Pubitemid 23328091)
38. Paquet-Durand F, Azadi S, Hauck SM, Ueffing M, van Veen T, Ekstrom P. Calpain is activated in degenerating photoreceptors in the rd1 mouse. J Neurochem. 2006; 96(3): 802-814.
39. Alderton JM, Steinhardt RA. Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. J Biol Chem. 2000; 275(13): 9452-9460. (Pubitemid 30185173)
40. Robles E, Huttenlocher A, Gomez TM. Filopodial calcium transients regulate growth cone motility and guidance through local activation of calpain. Neuron. 2003; 38(4): 597-609. (Pubitemid 36645034)
41. Farr C, Berger S. Measuring calpain activity in fixed and living cells by flow cytometry. J Vis Exp. 2010; 41. pii: 2050. doi: 10.3791/2050.
42. Squier MK, Miller AC, Malkinson AM, Cohen JJ. Calpain activation in apoptosis. J Cell Physiol. 1994; 159(2): 229-237. (Pubitemid 24141929)
43. Momeni HR, Kanje M. The calpain inhibitor VI prevents apoptosis of adult motor neurons. Neuroreport. 2005; 16(10): 1065-1068. (Pubitemid 41017607)
44. Momeni HR, Kanje M. Calpain inhibitors delay injury-induced apoptosis in adult mouse spinal cord motor neurons. Neuroreport. 2006; 17(8): 761-765. (Pubitemid 43804751)
45. Villa PG, Henzel WJ, Sensenbrenner M, Henderson CE, Pettmann B. Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis. J Cell Sci. 1998; 111(Pt 6): 713-722. (Pubitemid 28163880)
46. Rami A, Agarwal R, Botez G, Winckler J. mu-Calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage. Brain Res. 2000; 866(1-2): 299-312. (Pubitemid 30313034)
47. Springer JE, Azbill RD, Kennedy SE, George J, Geddes JW. Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment. J Neurochem. 1997; 69(4): 1592-600. (Pubitemid 27406960)
48. Kieran D, Greensmith L. Inhibition of calpains, by treatment with leupeptin, improves motoneuron survival and muscle function in models of motoneuron degeneration. Neuroscience. 2004; 125(2): 427-439. (Pubitemid 38446748)
49. Sakamoto YR, Nakajima TR, Fukiage CR, Sakai OR, Yoshida YR, Azuma MR, et al. Involvement of calpain isoforms in ischemia-reperfusion injury in rat retina. Curr Eye Res. 2000; 21(1): 571-580.
50. Blomgren K, Zhu C, Wang X, Karlsson JO, Leverin AL, Bahr BA, et al. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J Biol Chem. 2001; 276(13): 10191-10198.
51. Camins A, Verdaguer E, Folch J, Pallas M. Involvement of calpain activation in neurodegenerative processes. CNS Drug Rev. 2006; 12(2): 135-148. (Pubitemid 44300381)
52. Hara MR, Snyder SH. Cell signaling and neuronal death. Annu Rev Pharmacol Toxicol. 2007; 47(117-141).
53. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 1969; 164(880): 719-721.
54. Choi DW. Excitotoxic cell death. J Neurobiol. 1992; 23(9): 1261-1276.
55. Naslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. Jama. 2000; 283(12): 1571-1577. (Pubitemid 30161512)
56. Kelly BL, Ferreira A. beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. J Biol Chem. 2006; 281(38): 28079-28089. (Pubitemid 44414521)
57. Hirsch EC. Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease? Ann Neurol. 1992; 32 Suppl (S88-93).
58. Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AH. Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol. 1996; 39(3): 385-389. (Pubitemid 26100764)
59. Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, et al. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci. 2002; 5(8): 731-736. (Pubitemid 34827590)
60. Martin LJ, Price AC, Kaiser A, Shaikh AY, Liu Z. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death. Int J MoI Med. 2000; 5(1): 3-13.
61. Ludolph AC, Meyer T, Riepe MW. The role of excitotoxicity in ALS-what is the evidence? J Neurol. 2000; 247 Suppl 1: 17-16.
62. Shields DC, Banik NL. Pathophysiological role of calpain in experimental demyelination. J Neurosci Res. 1999; 55(5): 533-541. (Pubitemid 29117612)
63. Siman R, Noszek JC. Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron. 1988; 1(4): 279-287.
64. Pottorf WJ, 2nd, Johanns TM, Derrington SM, Strahler EE, Enyedi A, Thayer SA. Glutamate-induced protease-mediated loss of plasma membrane Ca2+ pump activity in rat hippocampal neurons. J Neuronem. 2006; 98(5): 1646-1656. (Pubitemid 44200453)
65. Bano D, Young KW, Guerin CJ, Lefeuvre R, Rothwell NJ, Naldini L, et al. Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity. Cell. 2005; 120(2): 275-285. (Pubitemid 40174769)
66. Hell JW, Westenbroek RE, Breeze LJ, Wang KK, Chavkin C, Catterall WA. N-methyl-D-aspartate receptor-induced proteolytic conversion of postsynaptic class C L-type calcium channels in hippocampal neurons. Proc Natl Acad Sci U S A. 1996; 93(8): 3362-3367. (Pubitemid 26125625)
67. Rardon DP, Cefali DC, Mitchell RD, Seiler SM, Hathaway DR, Jones LR. Digestion of cardiac and skeletal muscle junctional sarcoplasmic reticulum vesicles with calpain II. Effects on the Ca2+ release Channel. Circ Res. 1990; 67(1): 84-96. (Pubitemid 20223730)
68. French JP, Quindry JC, Falk DJ, Staib JL, Lee Y, Wang KK, et al. Ischemia-reperfusion-induced calpain activation and SERCA2a degradation are attenuated by exercise training and calpain inhibition. Am J Physiol Heart Circ Physiol. 2006; 290(1): H128-36.
69. Magnusson A, Haug LS, Walaas SI, Ostvold AC. Calcium-induced degradation of the inositol (1,4,5)-trisphosphate receptor/Ca(2+)-channel. FEBS Lett. 1993; 323(3): 229-232. (Pubitemid 23153475)
70. Tremper-Wells B, Vallano ML. Nuclear calpain regulates Ca2+-dependent signaling via proteolysis of nuclear Ca2+/calmodulin-dependent protein kinase type IV in cultured neurons. J Biol Chem. 2005; 280(3): 2165-2175.